PMC:7283670 / 88400-88670
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T478 | 58-83 | Disease | denotes | corona virus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T479 | 175-183 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T746 | 65-70 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T747 | 195-197 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T347 | 26-37 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T348 | 58-64 | Chemical | denotes | corona | http://purl.obolibrary.org/obo/CHEBI_37409 |
| T349 | 91-102 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T350 | 117-128 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T351 | 130-134 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T352 | 136-147 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T353 | 149-153 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T354 | 155-166 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T355 | 227-238 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T356 | 253-264 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T357 | 265-270 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T760 | 0-270 | Sentence | denotes | Favipiravir combined with tocilizumab in the treatment of corona virus disease 2019 Drug: favipiravir combined with tocilizumab, drug: favipiravir, drug: tocilizumab China, COVID‐19 150, all, 18–65 Treatment Experimental: favipiravir combined with tocilizumab group |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1962 | 58-70 | Species | denotes | corona virus | Tax:11118 |